IRPRESTAN

Q: Is this product safe to consume?

No. This product has been recalled due to: Detection of N-nitrosodiethylamine (NDEA) above the acceptable limit in the active substance sourced from Zhejiang Huahai. Potential effects: carcinogenic action and long-term health risk.

Detection of N-nitrosodiethylamine (NDEA) above the acceptable limit in the active substance sourced from Zhejiang Huahai. Potential effects: carcinogenic action and long-term health risk.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

App Store Google Play

Risk Level

Critical

Manufacturer

Actavis Group PTC ehf. z siedzibą w Islandii

Recall Date

24.01.2019

What You Should Know

Recommendations

Do not use medicine from this batch; check the batch number and return the product to the pharmacy; contact a doctor or pharmacist if in doubt.

Actions Taken

Withdrawal from the market of the specified batch of Irprestan 150 mg; decision by the Chief Pharmaceutical Inspector prohibiting placing the product on the market/withdrawing it with immediate enforc...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?

No. This product has been recalled due to: Detection of N-nitrosodiethylamine (NDEA) above the acceptable limit in the active substance sourced from Zhejiang Huahai. Potential effects: carcinogenic action and long-term health risk.

What should I do if I already bought this?

Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.

Which batches are affected?

Check the official report for specific batch details.

IRPRESTAN

What You Should Know

Recommendations

Actions Taken

Need Help?

Frequently Asked Questions

Other Recalled Products

Kwas traneksamowy Tillomed

Loperamid APTEO MED

Lorafen

Carmustine Accord

Taromentin